Showing results (31-40 of 182) with videos related to
Sort By:
Pageof 19
Breast Cancer Research and Treatment|March 17, 2006
Effect of adjuvant breast cancer chemotherapy on cognitive function from the older patient's perspectiveArti Hurria, Shari Goldfarb, Carol Rosen, et al.Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons|November 9, 2010
Bone scans, bisphosphonates, and a lack of acute changes within the mandiblePatrick G Morris, Clifford Hudis, Jorge Carrasquillo, et al.Breast Cancer Research and Treatment|June 4, 2017
The 21-gene recurrence score in special histologic subtypes of breast cancer with favorable prognosisGulisa Turashvili, Edi Brogi, Monica Morrow, et al.BMC Cancer|January 7, 2018
Breast carcinoma with 21-gene recurrence score lower than 18: rate of locoregional recurrence in a large series with clinical follow-upGulisa Turashvili, Edi Brogi, Monica Morrow, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 8, 2008
The safety of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel with trastuzumab in HER-2/neu overexpressed/amplified breast cancerChau Dang, Monica Fornier, Steven Sugarman, et al.PET Clinics|August 14, 2018
Overview of Breast Cancer TherapyTracy-Ann Moo, Rachel Sanford, Chau Dang, et al.Critical Reviews in Oncology/Hematology|November 14, 2006
Adjuvant treatment recommendations in older women with breast cancer: a survey of oncologistsArti Hurria, Arash Naeim, Elena Elkin, et al.JAMA Oncology|November 6, 2015
Cardiac Outcomes of Patients Receiving Adjuvant Weekly Paclitaxel and Trastuzumab for Node-Negative, ERBB2-Positive Breast CancerChau Dang, Hao Guo, Julie Najita, et al.Cancer|September 2, 2011
Radiation field design and regional control in sentinel lymph node-positive breast cancer patients with omission of axillary dissectionJeremy Setton, Hiram Cody, Lee Tan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2002
Assessment of molecular markers of clinical sensitivity to single-agent taxane therapy for metastatic breast cancerCatherine Van Poznak, Lee Tan, Katherine S Panageas, et al.Pageof 19